創薬サービスの世界市場レポート 2024年

創薬サービスの市場規模は近年急速に拡大しています。2023年の161億1,000万米ドルから2024年には183億米ドルへと、CAGR13.6％で拡大します。過去数年間に見られた成長は、研究開発（R&D）への投資の増加、疾病負担の拡大、医療イニシアチブに対する政府の資金援助や支援、開発業務受託機関（CRO）の出現、製薬・医療部門における個別化医療や薬剤再利用戦略への戦略的転換などの要因によるものです。

創薬試験への注目の高まりは、創薬サービス市場を推進すると予想されます。薬剤開発のライフサイクルは、安全で効果的なドラッグデリバリーを確保するために極めて重要です。このため、臨床試験は医薬品開発に不可欠な要素として脚光を浴びています。医療における医薬品開発と技術革新の重要性が高まるにつれ、創薬臨床試験の需要は世界中で増加しています。例えば、臨床試験を登録するプラットフォームであるClinicalTrials.govによると、2020年までに報告された臨床試験の総数は2021年3月時点で32万5,771件であり、2021年には36万2,501件に増加します。そのため、創薬臨床試験への注目度の高まりが創薬サービス市場の成長をけん引するとみられます。

創薬サービス市場は、創薬臨床試験への注目の高まりにより、大きな成長を遂げると思われます。臨床試験は、安全で効果的なドラッグデリバリーを保証する、医薬品開発のライフサイクルの重要な側面となっています。医薬品開発と医療の革新に重点が置かれるようになり、創薬臨床試験の世界の需要は増加傾向にあります。ClinicalTrials.govは、2021年3月の臨床試験件数が32万5,771件から2021年には36万2,501件に大幅に増加すると報告しており、創薬試験の重要性が高まっていることを浮き彫りにしています。この動向は、創薬サービス市場を前進させることが期待されます。

2023年の創薬サービス市場で最大の地域は北米でした。創薬サービス市場レポートの対象地域は、アジア太平洋、西欧、中東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の創薬サービス市場の促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の創薬サービスの市場規模実績と成長、2018～2023年
• 世界の創薬サービス市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界の創薬サービス市場、タイプ別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 化学サービス
• 生物サービス
• 世界の創薬サービス市場、プロセス別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 対象の選択
• 対象の検証
• ヒットツーリードの識別
• リードの最適化
• 候補の検証
• 世界の創薬サービス市場、医薬品のタイプ別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 生物製剤
• 低分子医薬品
• 世界の創薬サービス市場、エンドユーザー別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 製薬会社とバイオテクノロジー会社
• 学術機関
• その他

第7章 地域と国の分析

• 世界の創薬サービス市場、地域別、実績と予測、2018～2023年、2023～2028年、2033年
• 世界の創薬サービス市場、国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 創薬サービス市場の競合情勢
• 創薬サービス市場の企業プロファイル
  • Thermo Fisher Scientific Inc.
  • Albany Molecular Research Inc.
  • Charles River Laboratories International Inc.
  • Laboratory Corporation of America Holdings
  • Domainex Ltd

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の展望と潜在性分析

第35章 付録

Drug Discovery Services Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug discovery services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug discovery services? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drug discovery services market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Type: Chemistry Services; Biology Services
• 2) By Process: Target Selection; Target Validation; Hit-to-Lead identification; Lead Optimization; Candidate Validation
• 3) By Drug Type: Biologics Drug ; Small Molecule Drug
• 4) By End user: Pharmaceutical and Biotechnology Companies; Academic Institutes; Other End Users
• Companies Mentioned: Thermo Fisher Scientific Inc.; Albany Molecular Research Inc.; Charles River Laboratories International Inc.; Laboratory Corporation of America Holdings; Domainex Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Drug discovery services involve the process of identifying potential new medicines, utilizing a combination of scientific disciplines such as biology, chemistry, and pharmacology. These services are structured across four stage such as early drug discovery, pre-clinical phase, clinical phases, and regulatory approval.

The primary types of drug discovery services include chemistry services and biology services. Chemistry services focus on the design and synthesis of biologically active molecules, aiming to discover and optimize chemical compounds for drug development. This involves the utilization of technologies like high-performance liquid chromatography and high-field NMR for the quick and efficient synthesis, analysis, and purification of compound libraries. Key processes within chemistry services include target selection, target validation, hit-to-lead identification, lead optimization, and candidate validation, incorporating various drug types such as biologics and small molecules. End-users of drug discovery services encompass pharmaceutical and biotechnology companies, academic institutes, and other entities involved in the drug discovery process.

The drug discovery services market research report is one of a series of new reports from The Business Research Company that provides drug discovery services market statistics, including drug discovery services industry global market size, regional shares, competitors with a drug discovery services market share, detailed drug discovery services market segments, market trends and opportunities, and any further data you may need to thrive in the drug discovery services industry. This drug discovery services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug discovery services market size has grown rapidly in recent years. It will grow from $16.11 billion in 2023 to $18.3 billion in 2024 at a compound annual growth rate (CAGR) of 13.6%. The growth observed in the historical period can be attributed to factors such as increased investment in research and development (R&D), an expanding disease burden, government funding and support for healthcare initiatives, the emergence of contract research organizations (CROs), and a strategic shift towards personalized medicine and drug repurposing strategies in the pharmaceutical and healthcare sectors.

The drug discovery services market size is expected to see rapid growth in the next few years. It will grow to $30.1 billion in 2028 at a compound annual growth rate (CAGR) of 13.2%. The anticipated growth in the forecast period can be attributed to changes in regulatory frameworks, advancements in drug delivery systems, a growing interest in immunotherapy, a shift towards RNA-based therapeutics, and an increased focus on targeting rare diseases in the pharmaceutical and healthcare sectors. Major trends in the forecast period encompass the adoption of advanced technologies, the growth of biologicals and biopharmaceuticals, increased use of high-throughput screening, advancements in virtual screening techniques, and a focus on regenerative medicine.

The growing focus on drug discovery trials is expected to propel the drug discovery services market. The drug development life cycle is critical for ensuring safe and effective drug delivery. Due to this, clinical trials are gaining prominence as an essential component of drug development. With the increasing importance of drug development and innovation in healthcare, the demand for drug discovery trials worldwide has increased. For instance, according to ClinicalTrials.gov, a platform for registering clinical trials, the total number of clinical trials reported until 2020 was 325,771 in March 2021, rising to 362,501 in 2021. Therefore, the growing focus on drug discovery trials will drive the growth of the drug discovery services market.

The drug discovery services market is set to experience significant growth due to the increasing focus on drug discovery trials. Clinical trials have become a crucial aspect of the drug development life cycle, ensuring the safe and effective delivery of drugs. With a heightened emphasis on drug development and healthcare innovation, the global demand for drug discovery trials is on the rise. ClinicalTrials.gov reported a substantial increase from 325,771 clinical trials in March 2021 to 362,501 in 2021, highlighting the growing significance of drug discovery trials. This trend is expected to propel the drug discovery services market forward.

The drug discovery services market is anticipated to witness growth driven by the rising prevalence of chronic diseases. Chronic diseases, characterized by long-lasting health conditions, necessitate ongoing management. Drug discovery services play a pivotal role in identifying and developing new medications for the treatment of chronic diseases. According to the National Library of Medicine, the US is expected to experience a 99.5% increase in the number of individuals aged 50 and older with at least one chronic condition, reaching 142.66 million by 2050. This increase in chronic diseases is poised to contribute significantly to the growth of the drug discovery services market.

Technological advancements emerge as a key trend shaping the drug discovery services market. Major companies in drug development services are responding to market demand by integrating robotics and automated screening to enhance the overall speed of drug discovery. This technological progression provides key players with a competitive edge. For instance, Arctoris Ltd., a UK-based platform company, introduced Ulysses in February 2021. This fully automated robotic platform enhances drug discovery by generating high-quality, measurable, and auditable datasets swiftly, facilitating informed decision-making in the early stages of drug development.

Major companies in the drug discovery services market are concentrating on product innovations and developing new solutions to strengthen their market positions. The focus is on enhancing efficiency through process visualization and centralized data management. An example is Fujitsu's launch of the bio drug design accelerator platform in May 2023. This platform supports peptide drug discovery scientists in pharmaceutical companies by streamlining the 'design, make, test, analyze' (DMTA) cycles. It aims to contribute to faster and more efficient drug discovery by visualizing amino acid sequences and organizing research results for peptide drug development, showcasing the industry's commitment to innovative solutions.

In January 2023, Sygnature Discovery, a prominent UK-based integrated Drug Discovery firm, successfully concluded the acquisition of SB Drug Discovery for an undisclosed sum. This strategic move is expected to provide mutual strategic advantages, facilitating the expansion of both companies and enhancing their respective capabilities. The acquisition aligns with Sygnature's strategic plan, demonstrating a commitment to ongoing investment in the expansion of its leading integrated drug discovery solutions. SB Drug Discovery, the acquired company, is a UK-based entity specializing in providing crucial data for novel drug development through services such as cell line generation, assay development, and compound screening.

Major companies operating in the drug discovery services market report are Thermo Fisher Scientific Inc., Albany Molecular Research Inc., Charles River Laboratories International Inc., Laboratory Corporation of America Holdings, Domainex Ltd., GenScript Biotech Corporation, Pharmaceutical Product Development LLC, Advinus Therapeutics Pvt. Ltd., Jubilant Biosys Ltd., Evotec AG, Syngene International Ltd., Bayer AG, Merck KGaA, Ubiquigent Ltd., Eurofins Scientific SE, AppTec Laboratory Services Inc., GVK Biosciences Private Limited, Aurigene Discovery Technologies Limited, Viva Biotech Holdings, Pharmaron Beijing Co. Ltd., Selcia Limited, Concept Life Sciences Group Limited, BioDuro LLC, ChemPartner Corporation, Aptuit LLC, Sygnature Discovery Limited, Peak Proteins Ltd., SRI International, BioAscent Discovery Limited, Sai Life Sciences Limited, Promega Corporation, MedChemExpress LLC, Aragen Bioscience Inc., WuXi STA, BioNTech SE, Moderna Inc., Gilead Sciences Inc., Vertex Pharmaceuticals Incorporated, Regeneron Pharmaceuticals Inc., Amgen Inc., and Bristol-Myers Squibb Company.

North America was the largest region in the drug discovery services market in 2023. The regions covered in the drug discovery services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drug discovery services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The drug discovery services market includes revenues earned by entities by providing pharmaceutical services, drug metabolism and pharmacokinetics (DMPK) services, biological services, and medicinal chemistry. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Drug Discovery Services Market Characteristics

3. Drug Discovery Services Market Trends And Strategies

4. Drug Discovery Services Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Drug Discovery Services Market Size and Growth

• 5.1. Global Drug Discovery Services Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Drug Discovery Services Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Drug Discovery Services Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Drug Discovery Services Market Segmentation

• 6.1. Global Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Chemistry Services
• Biology Services
• 6.2. Global Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Target Selection
• Target Validation
• Hit-to-Lead identification
• Lead Optimization
• Candidate Validation
• 6.3. Global Drug Discovery Services Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Biologics Drug
• Small Molecule Drug
• 6.4. Global Drug Discovery Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Pharmaceutical and Biotechnology Companies
• Academic Institutes
• Other End Users

7. Drug Discovery Services Market Regional And Country Analysis

• 7.1. Global Drug Discovery Services Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Drug Discovery Services Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Drug Discovery Services Market

• 8.1. Asia-Pacific Drug Discovery Services Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Drug Discovery Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Drug Discovery Services Market

• 9.1. China Drug Discovery Services Market Overview
• 9.2. China Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Drug Discovery Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Drug Discovery Services Market

• 10.1. India Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Drug Discovery Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Drug Discovery Services Market

• 11.1. Japan Drug Discovery Services Market Overview
• 11.2. Japan Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Drug Discovery Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Drug Discovery Services Market

• 12.1. Australia Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Drug Discovery Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Drug Discovery Services Market

• 13.1. Indonesia Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Drug Discovery Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Drug Discovery Services Market

• 14.1. South Korea Drug Discovery Services Market Overview
• 14.2. South Korea Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Drug Discovery Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Drug Discovery Services Market

• 15.1. Western Europe Drug Discovery Services Market Overview
• 15.2. Western Europe Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Drug Discovery Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Drug Discovery Services Market

• 16.1. UK Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Drug Discovery Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Drug Discovery Services Market

• 17.1. Germany Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Drug Discovery Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Drug Discovery Services Market

• 18.1. France Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Drug Discovery Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Drug Discovery Services Market

• 19.1. Italy Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Drug Discovery Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Drug Discovery Services Market

• 20.1. Spain Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Drug Discovery Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Drug Discovery Services Market

• 21.1. Eastern Europe Drug Discovery Services Market Overview
• 21.2. Eastern Europe Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Drug Discovery Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Drug Discovery Services Market

• 22.1. Russia Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Drug Discovery Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Drug Discovery Services Market

• 23.1. North America Drug Discovery Services Market Overview
• 23.2. North America Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Drug Discovery Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Drug Discovery Services Market

• 24.1. USA Drug Discovery Services Market Overview
• 24.2. USA Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Drug Discovery Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Drug Discovery Services Market

• 25.1. Canada Drug Discovery Services Market Overview
• 25.2. Canada Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Drug Discovery Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Drug Discovery Services Market

• 26.1. South America Drug Discovery Services Market Overview
• 26.2. South America Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Drug Discovery Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Drug Discovery Services Market

• 27.1. Brazil Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Drug Discovery Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Drug Discovery Services Market

• 28.1. Middle East Drug Discovery Services Market Overview
• 28.2. Middle East Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Drug Discovery Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Drug Discovery Services Market

• 29.1. Africa Drug Discovery Services Market Overview
• 29.2. Africa Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Drug Discovery Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Drug Discovery Services Market Competitive Landscape And Company Profiles

• 30.1. Drug Discovery Services Market Competitive Landscape
• 30.2. Drug Discovery Services Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Albany Molecular Research Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Charles River Laboratories International Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Laboratory Corporation of America Holdings
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Domainex Ltd
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Drug Discovery Services Market Competitive Benchmarking

32. Global Drug Discovery Services Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Drug Discovery Services Market

34. Drug Discovery Services Market Future Outlook and Potential Analysis

• 34.1 Drug Discovery Services Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Drug Discovery Services Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Drug Discovery Services Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer